Back to Journals » OncoTargets and Therapy » Volume 13

Case report

Ruxolitinib Plus Decitabine Effectively Treats Myelodysplastic Syndrome/Myeloproliferative Neoplasm, Unclassifiable, by Decreasing the Variant Allele Frequency of KRAS

       
Total article views   HTML views PDF downloads Totals
4,290 Dovepress* 3,684+ 713 4,397
PubMed Central* 606 120 726
Totals 4,290 833 5,123
*Since 9 October 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar